SUVEN LIFE SCIENCES
Back to Income Statement
|
SUVEN LIFE SCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-105 Cr | ₹-118 Cr | ₹-122 Cr | ₹-72 Cr | ₹-94 Cr |
What is the latest Consolidated Net Profit of SUVEN LIFE SCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-105 Cr |
| Mar2024 | ₹-118 Cr |
| Mar2023 | ₹-122 Cr |
| Mar2022 | ₹-72 Cr |
| Mar2021 | ₹-94 Cr |
How is Consolidated Net Profit of SUVEN LIFE SCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-105 Cr | Negative | |
| Mar2024 | ₹-118 Cr | Negative | |
| Mar2023 | ₹-122 Cr | Negative | |
| Mar2022 | ₹-72 Cr | Negative | |
| Mar2021 | ₹-94 Cr | - | |
Compare Consolidated Net Profit of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹3,602.1 Cr | -1.1% | -13.6% | 15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -1.1% |
-13.6% |
15.7% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses